Publications & News
Life Sciences Law Firm Index Ranks WilmerHale Among Top 10 Deals Firms

Life Sciences Law Firm Index Ranks WilmerHale Among Top 10 Deals Firms

January 12, 2017

WilmerHale has been named among the Top 10 Deal Firms by the Life Sciences Law Firm Index, a guide published by Breaking Media and Lake Whillans that identifies the most active and relevant law firms for life science companies. The Index, which publishes updates concerning various law firm practice strengths throughout the year, kicked off its 2017 rankings by researching and identifying the most active deals firms with a focus on mergers and acquisitions, IPOs, financing and private equity work.

The Index identifies the most active and relevant law firms for life science companies. It publishes rankings throughout the year that focus on various practice areas. In 2016, WilmerHale was recognized in the Index as among the top two life sciences law firms, the top two patent law firms and among the top 10 firms for thought leadership in the field.

WilmerHale has represented life sciences clients across the United States and Europe for more than four decades. From biotechnology, pharmaceutical, diagnostic and medical device companies at all stages of growth to other institutions in the space, including venture capitalists, investment banks, universities and others, its talented lawyers understand the business of life sciences clients and the changing regulatory and competitive demands they face. Learn more about the firm's Life Sciences Practice.